To obtain access to any datasets listed on this site, you must first receive approval from NIDA Datashare's Data Access Committee (DAC).

Please submit your request by sending your request to NIDA_Datashare_DAC@nih.gov along with the following information:

  • Your name, title, and organization
  • Study Number and Study Title
  • The specific dataset(s) you are requesting
  • The intended use or purpose of the data
  • Willingness to comply with the NIDA Datashare Registration Agreement
Once your request is reviewed, you will receive instructions on how to proceed.

Thank you for your cooperation.

NIDA-CSP-1008B

Division
DTMC
HEAL Study
No
Investigator(s)
Peter Bridge, M.D.
Title
A Multicenter Safety Trial of Buprenorphine/Naloxone for the Treatment of Opiate Dependence
Short Description
This 52-week study is designed to determine the efficacy and safety of a buprenorphine/naloxone sublingual tablet formulation as an office-based therapy for opiate-dependence treatment.
Release Date
Dec 04, 2014
Description

This 52-week study is designed to determine the efficacy and safety of a buprenorphine/naloxone sublingual tablet formulation as an office-based therapy for opiate-dependence treatment. The developmental objective for this combination product is an expansion of therapeutic options for the treatment of opiate dependence.

Keywords
phase 3
buprenorphine
naloxone
opiate
Assessments
Risk Assessment Battery
Treatment Services Review
Accessibility Notice

Please note that the supplementary documents may not be fully Section 508 compliant. Please contact us for assistance.

Study Links
Study Information
CSP-1008B Study Information